Pricing Log in Create free account

Latigo Biotherapeutics Inc (LTGO) vs Obsidian Therapeutics, Inc (OBX)

Latigo Biotherapeutics Inc and Obsidian Therapeutics, Inc are both Biotechnology companies. Latigo Biotherapeutics Inc is the larger, with a market value of $896.4M against $795.6M — 1.1× the size. Across the 1 metrics below, Latigo Biotherapeutics Inc leads on 1 and Obsidian Therapeutics, Inc on 0.

Valuation

Metric LTGO OBX Biotechnology median
P/E n/m — 11.58
P/S n/m n/m 9.61
P/B 1.30 n/m 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales n/m n/m 9.43
Earnings yield (611.98%) — (32.28%)
Free cash flow yield 0.00% 0.00% (22.27%)

Profitability

Metric LTGO OBX Biotechnology median
Gross margin — — 68.81%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin — — 0.00%
Return on equity 0.00% — (50.30%)
Return on assets 0.00% — (45.47%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LTGO OBX Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) — (11.60%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric LTGO OBX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 29.11 4.21 4.74
Net debt to EBITDA — 0.77 1.01

Dividend

Metric LTGO OBX Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric LTGO OBX Biotechnology median
Market cap 896.37m 795.63m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack